Prediction of sustained viral response in chronic HCV patients treated with pegylated interferon and ribavirin /
Rabab Abdelsalam Nashaat Moharram
Prediction of sustained viral response in chronic HCV patients treated with pegylated interferon and ribavirin / توقع الاستجابة طويلة المدى لدى المرضى المصابين بفيروس"سى" المزمن مع العلاج بالانتلافيرون طويل المفعول والريبافيرين Rabab Abdelsalam Nashaat Moharram ; Supervised Gamal Eldin Esmat Mohamed , Ashraf Omar Abdelaziz , Abdelrahman Nabawi Zekri - Cairo : Rabab Abdelsalam Nashaat Moharram , 2014 - 126 P. : charts ; 25cm
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine
In this study, the concept of rapid viral response (RVR) and very early viral response (VEVR) has been validated in predicting SVR in chronic HCV patients treated with pegylated interferon plus ribavirin specially regarding the PPV and the NPV, as there is limited information available regarding treating hepatitis C genotype 4.This prospective cohort study was performed on 125 out-patients with chronic HCV infection who attended to the N.H.T.M.R.I & were candidates for treatment with pegylated interferon alpha & ribavirin. Out of the 125 patients, 20 patients were withdrawn due to non-response at week
HCV Interferon and ribavirin Sustained viral response
Prediction of sustained viral response in chronic HCV patients treated with pegylated interferon and ribavirin / توقع الاستجابة طويلة المدى لدى المرضى المصابين بفيروس"سى" المزمن مع العلاج بالانتلافيرون طويل المفعول والريبافيرين Rabab Abdelsalam Nashaat Moharram ; Supervised Gamal Eldin Esmat Mohamed , Ashraf Omar Abdelaziz , Abdelrahman Nabawi Zekri - Cairo : Rabab Abdelsalam Nashaat Moharram , 2014 - 126 P. : charts ; 25cm
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine
In this study, the concept of rapid viral response (RVR) and very early viral response (VEVR) has been validated in predicting SVR in chronic HCV patients treated with pegylated interferon plus ribavirin specially regarding the PPV and the NPV, as there is limited information available regarding treating hepatitis C genotype 4.This prospective cohort study was performed on 125 out-patients with chronic HCV infection who attended to the N.H.T.M.R.I & were candidates for treatment with pegylated interferon alpha & ribavirin. Out of the 125 patients, 20 patients were withdrawn due to non-response at week
HCV Interferon and ribavirin Sustained viral response